Brief: Adaptive Biotechnologies Q4 EPS USD -0.09
05/02/2026 21:05
Feb 05 (Reuters) - Adaptive Biotechnologies Q4 revenue USD 71.681 million vs. IBES estimate USD 59.4 million. Q4 operating expenses USD 84.454 million Q4 operating income USD -12.773 million Q4 net income USD -13.579 million Q4 adjusted EBITDA USD 4.1 million vs. IBES estimate USD -7.45 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates